Home›Quality Guide

HPLC 3D Virtual Instrument Laboratory

 

Developed by: Pharma Quality System • Resource type: Interactive HPLC instrument training • Last reviewed: September 6, 2026
PQS INSTRUMENT TRAINING • HPLC • INTERACTIVE 3D

HPLC 3D Virtual Instrument Laboratory

Practice the operating logic of a pharmaceutical HPLC system in an interactive 3D environment. Work through startup, priming, column handling, method setup, equilibration, detector readiness, system suitability, sample analysis, CDS review and common fault scenarios.

GUIDED TRAINING FREE PRACTICE SYSTEM SUITABILITY FAULT TRAINING
Opens the full interactive simulator in a separate training workspace.
What makes this different from a static HPLC lesson?

This training tool is built around cause and effect. Controls are not decorative: operating choices change instrument state, readiness, pressure, detector response, chromatographic behavior, system-suitability outcome and whether a sample result can be treated as reportable in the training scenario.

What You Can Practice

Instrument StartupPower-up, solvent inspection, purge-path handling, priming and pump readiness.
Column & Oven HandlingOpen the oven, install or remove the column, close the oven and understand readiness interlocks.
Method SetupWork with flow, wavelength, oven temperature, injection volume and mobile-phase composition.
Detector ReadinessUse lamp warm-up, equilibration and autozero before analytical injection.
System SuitabilityRun and review a fictional training SST using resolution, tailing, plate count, S/N and pressure behavior.
Sample & CDS ReviewLoad vials, run the sequence, view chromatograms, inspect results and review the training audit trail.

Two Training Modes

Guided Training

Follow the instrument workflow step by step. The simulator highlights the relevant control and explains what the action does, why it matters and what state is expected next.

Free Practice

Operate the system without a fixed sequence. Correct and incorrect choices create different instrument states, allowing you to explore consequences and troubleshoot the run.

Training Workflow

The generic training workflow is intentionally structured like an operator exercise rather than a passive animation:

Power → solvent inspection → purge/prime → column installation → method setup → analytical flow → UV lamp warm-up → equilibration → autozero → vial loading → SST → explicit SST review → sample run → CDS/result review

Fault & Troubleshooting Practice

The simulator includes training faults so the user can see how abnormal conditions affect readiness or the analytical outcome. Scenarios include examples such as an air bubble, blocked frit, leak, empty solvent, column-direction deviation, carryover and wrong-vial selection.

Important training principle:
A chromatogram is not reviewed in isolation. Instrument condition, sequence control, system suitability, sample identity, method settings and the data trail all contribute to whether a result is scientifically usable.

Who Is This For?

  • QC analysts learning the operating sequence of an HPLC system.
  • Pharmaceutical-science students who want an interactive instrument view rather than a diagram alone.
  • QA or laboratory reviewers who want to understand where instrument-state and data-review decisions arise.
  • New laboratory personnel preparing for supervised practical training.

Related PQS HPLC Training

Educational scope: PQS HPLC 3D Virtual Instrument Laboratory is an original interactive training tool developed for Pharma Quality System. The method values, acceptance criteria, timings and scenarios inside the simulator are fictional training examples. The simulator does not replace approved laboratory SOPs, instrument-vendor instructions, equipment qualification, method-specific requirements or supervised hands-on training.
Ready to operate the virtual HPLC? Use Guided Training for your first run, then repeat the workflow in Free Practice. Launch the HPLC 3D Virtual Laboratory →
© 2026 Pharma Quality System. All rights reserved.

Comments

Post a Comment

Popular posts from this blog

OOS in Pharmaceutical Industry: Investigation, Phase I & II, Examples

Image
Published by: Pharma Quality System Editorial Team • Editorial basis: FDA OOS guidance  (2022) ,  21 CFR 211.192,  Health Canada GUI-0001, and current GMP quality-system principles Pharmaceutical Quality Control & Laboratory Investigations An Out-of-Specification (OOS) result is not simply a failed number to retest until it passes. It is a quality signal that requires a scientifically sound, documented investigation to determine whether the result reflects laboratory error, manufacturing variability, material failure, or another assignable cause. Quick answer In pharmaceutical testing, OOS means a test result falls outside an established specification or acceptance criterion. FDA expects the result to be investigated rather than ignored or averaged away. The investigation generally begins with a focused laboratory assessment and expands to a full-scale investigation when a conclusive lab...
Read more

Health Canada GMP Guidelines (GUI-0001): Requirements, Inspections & Drug Establishment Licences

Image
  Published by: Pharma Quality System Editorial Team • Editorial basis: Health Canada GUI-0001, GUI-0002, GMP inspection, Drug Establishment Licence and risk-classification guidance CANADA GMP • GUI-0001 • DEL • INSPECTIONS Health Canada's GMP framework is built around Part C, Division 2 of the Food and Drug Regulations. GUI-0001 explains how regulated establishments should meet those GMP expectations, while Drug Establishment Licence requirements under Division 1A determine which Canadian activities may legally be conducted. Quick answer GUI-0001 is Health Canada's main GMP guide for drug products. It interprets GMP requirements in Part C, Division 2 of the Food and Drug Regulations and is used by Health Canada during inspections. Canadian establishments that fabricate, package/label, distribute, import, wholesale or test drugs generally need a valid Drug Establishment Licence (DEL) for ...
Read more

Data Integrity in Pharmaceutical Industry: ALCOA+ Principles, FDA Guidance & Examples

Image
  Published by:   Pharma Quality System Editorial Team   • Editorial basis: FDA data-integrity guidance (2018), Health Canada GUI-0001 and GUI-0050, WHO pharmaceutical data-integrity principles and 21 CFR Part 11 Last reviewed: September 4, 2026 GMP • QUALITY SYSTEMS • LABORATORY & MANUFACTURING DATA Pharmaceutical decisions are only as reliable as the data behind them. Data integrity means that records remain complete, consistent, accurate, attributable, and trustworthy throughout their lifecycle—from the moment data are generated until they are reviewed, reported, retained, and retrieved. Quick answer In the pharmaceutical industry, data integrity is the assurance that data are reliable and remain trustworthy throughout their lifecycle. WHO describes the expected characteristics using ALCOA+ : Attributable, Legible, Contemporaneous, Original or a true copy, Accurate, Complete, Consistent, Enduring, and Available. FDA expects firms to use meani...
Read more